Zarnestra
Zarnestra
Zarnestra (pronunciation: /zɑːrˈnɛstrə/) is a type of antineoplastic agent used in the treatment of cancer. It is also known as tipifarnib and is classified under the group of drugs known as farnesyltransferase inhibitors.
Etymology
The name 'Zarnestra' is a brand name and does not have a known etymology. The generic name 'tipifarnib' is derived from the type of enzyme it inhibits - farnesyltransferase.
Usage
Zarnestra is used in the treatment of various types of cancers, including leukemia, lymphoma, and solid tumors. It works by inhibiting the enzyme farnesyltransferase, which is involved in the growth of cancer cells.
Related Terms
- Antineoplastic agent: A type of drug that inhibits the growth and spread of cancer cells.
- Farnesyltransferase inhibitor: A type of drug that inhibits the enzyme farnesyltransferase, which is involved in the growth of cancer cells.
- Leukemia: A type of cancer that affects the blood and bone marrow.
- Lymphoma: A type of cancer that begins in the cells of the immune system.
- Solid tumor: A type of cancer that begins in the solid tissues of the body, such as the organs.
External links
- Medical encyclopedia article on Zarnestra
- Wikipedia's article - Zarnestra
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski